Biology

Dr. Mayfield is currently an SVP of Business Development and Strategy at Flagship Pioneering, leveraging his expertise in licensing, transactions, and establishing strategic collaborations within the biotechnology, pharmaceutical, and diagnostics industries to help Flagship’s portfolio companies meet their corporate objectives and accelerate their company mission. Previously, John led Business Development as CBO at Be Biopharma, helping to drive towards its goal to fully unleash the power of B cell medicines. John has additionally held roles at EQRx where he was most recently the Vice President, Corporate and Business Development. At EQRx, he led a team that executed significant deal-flow spanning co-development and co-commercialization partnerships to licensing and collaboration agreements for preclinical, clinical and commercial-stage medicines. Prior to EQRx, he held business development roles of increasing responsibility at Voyager Therapeutics and Foundation Medicine.

Early in his career, at Illumina, John focused on product development utilizing whole genome data. He holds a Ph.D. from the Plant Molecular and Cellular Biology Program at the University of Florida and a Bachelor of Science in biology from Southeast Missouri State University. John conducted postdoctoral research at the Washington University School of Medicine in St. Louis and Duke University.